Skip to content
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Clinicians
Member Value Tools
Practice Insights
Verana Trial Connect
Quality Measures Dashboards
MIPS Advisory Offerings
Manual Data Entry
Verana Research Network
Evolve Registry
Life Sciences
Clinical Development
HEOR & Medical Affairs
Commercialization
Research
Partners
Societies
CROs
Technology and Data
Company
About
Team
Press
Blog
Careers
Privacy
Patient Privacy
Privacy Policy
Products
Ophthalmology Qdata
Anti-VEGF Market Tracker
Diabetic Retinopathy
Dry Eye Disease
Cataracts
Geographic Atrophy
Glaucoma
Neovascular AMD
Retinitis Pigmentosa
Thyroid Eye Disease
Uveitic Macular Edema
Qdata Explorer
Other Ophthalmic Conditions
Neurology Qdata
Multiple Sclerosis
Parkinson’s Disease
Spinal Muscular Atrophy
Other Neurological Conditions
Urology Qdata
Benign Prostatic Hyperplasia
Bladder Cancer
Prostate Cancer
Other Urological Conditions
Clinical Trials
Site Explorer
Solutions
Clinical Research
Trial Design
Protocol Optimization & Site Selection
Patient Recruitment
Prospective Evidence Generation (PEG)
Market Insights
Market Tracking
Brand Switching
Prescriber Mapping
RWE Studies
Patient Segmentation
Safety Studies
Natural History of Disease / Disease Progression
Comparative Effectiveness
Treatment Patterns & Outcomes
Healthcare Resource Utilization (HCRU) Cost
Phase IV Studies / Surveillance
Contact Us
Abstract
Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System: A Subgroup Analysis from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)
November 3, 2025
Read More...
Real-World Clinical and Anatomical Outcomes in Patients with Diabetic Macular Edema Treated with Faricimab: The FARETINA-DME Study
May 9, 2024
Read More...
IRIS® Registry Analysis of Anti-VEGF Treatment in Patients With Coexisting Neovascular Age-Related Macular Degeneration and Geographic Atrophy
May 9, 2024
Read More...
A Natural Language Processing Approach to Identify Patients with Uveitic Macular Edema in the IRIS®️ Registry
May 6, 2024
Read More...
Automated Segmentation of Geographic Atrophy Using Machine Learning on Real-World Fundus Autofluorescence Ophthalmic Images in the IRIS®️ Registry
May 6, 2024
Read More...
Real-World Clinical and Anatomical Outcomes in Patients With Neovascular Age-Related Macular Degeneration Treated With Faricimab: The FARETINA-AMD Study
May 6, 2024
Read More...
Leveraging real-world data from the American Academy of Ophthalmology’s IRIS®️ Registry to evaluate the use and impact of approved medical devices and software algorithms in support of FDA strategic priorities
April 10, 2024
Read More...
Evaluation of treatment and switching patterns for Dry Eye Disease medications using linked EHR and Claims data
October 19, 2023
Read More...
Impact of Visual Impairment on Health Care Resource Utilization and Associated Costs for Real-World Patients with Geographic Atrophy
October 3, 2023
Read More...
Modeling for Missing data
May 1, 2023
Read More...
1
2
3
…
6
Next »